STOCK TITAN

Flotek Announces First Quarter 2024 Results Reflecting Improved Profitability

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Flotek Industries, Inc. announced improved profitability in Q1 2024 with significant growth in gross profit and adjusted EBITDA. Net income increased by $10.8 million compared to Q1 2023, excluding non-cash gains. The company expects a boost in margins and adjusted EBITDA for 2024, following cost reductions in 2023. CEO Dr. Ryan Ezell highlighted positive financial trends and revenue growth in various segments, emphasizing resilience and profitability.

Positive
  • Significant growth in gross profit, adjusted gross profit, and adjusted EBITDA in Q1 2024.

  • Improved net income by $10.8 million compared to Q1 2023, excluding non-cash gains.

  • Anticipated substantial increase in margins and adjusted EBITDA for full year 2024.

  • CEO highlighted positive financial trends and revenue growth in key segments.

Negative
  • Decline in total revenues by 16% in Q1 2024 compared to Q1 2023.

  • Net income decrease from $21.3 million in Q1 2023 to $1.6 million in Q1 2024.

  • External chemistry customer sales declined sequentially in Q1 2024.

Insights

Flotek Industries' first quarter results exhibit a notable disparity between profitability and revenue streams. The company's gross profit margin saw an impressive uptick to 22%, a clear indication that cost-cutting measures and operational efficiencies are starting to bear fruit. This improvement is vital, as it suggests a strengthening core business model, which is important for sustainable growth.

On the other hand, the 16% decline in total revenues sparks concern. It's essential to dissect the composition of this decline. If it's predominantly due to cyclical or one-off events, it may be less worrying. However, if the revenue dip reflects a loss of market share or competitive edge, that could spell trouble for future earnings stability. An investor should weigh these contrasting aspects when considering Flotek's financial health.

From a market perspective, Flotek's sequential growth in ProFrac related revenue and the increase in data analytics segment revenues are positive signals. They reflect the company's potential to tap into niche markets with specialized services. The 27% year-over-year growth in external chemistry customer sales is another highlight, hinting at a robust product offering that resonates with the market needs.

However, the investor should be cautious. Seasonal fluctuations are normal, but the ability to smooth out these peaks and troughs will be a test of Flotek's market strategy and resilience. Revenue growth in subsequent quarters, particularly in the data analytics and external chemistry segments, will be important indicators of the company’s ability to sustain and leverage its market position.

Investors should also consider the underlying risks associated with Flotek’s financial structure. The significant year-over-year improvement in net income and the reduction in borrowings under the Asset Based Loan by 58% are definitely positives, implying a stronger balance sheet. However, the dramatic swing in net income, driven in part by non-cash gains the previous year, calls for a critical eye. Investors need to assess the quality of earnings, distinguishing between operational performance and financial engineering.

Moreover, given the industry's volatility, Flotek's forward-looking statements about margin improvements and adjusted EBITDA need to be scrutinized against industry benchmarks and economic trends. An informed investor should consider not just the numbers but the narrative behind them and the external factors that might influence future performance.

HOUSTON, May 7, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced operational and financial results for the quarter ended March 31, 2024, highlighted by significant improvement in profitability metrics as compared to the first quarter of 2023.

Financial Summary (in thousands, except per share amounts)



Three months ended March 31,





2024


2023


% Change








Total Revenues


$                    40,374


$                     48,007


(16) %

Gross Profit


$                      8,821


$                       1,880


369 %

Adjusted Gross Profit (1)


$                    10,075


$                       2,647


281 %

Net Income


$                      1,562


$                     21,343


(93) %

Diluted Income (Loss) Per Share


$                        0.05


$                        (0.12)


n/a

Adjusted EBITDA (1)


$                      4,026


$                      (3,851)


n/a

First Quarter 2024 Highlights

  • Reported net income of $1.6 million compared to net income of $21.3 million for the first quarter of 2023. Net income for the first quarter of 2023 benefited from $30.6 million in non-cash gains. Excluding these non-cash gains, first quarter 2024 net income improved by $10.8 million.
  • Delivered significant year-over-year improvements in gross profit, adjusted gross profit(1) and adjusted EBITDA(1) of $6.9 million, $7.4 million and $7.9 million, respectively.
  • Realized gross profit margin and adjusted gross profit margin(1) of 22% and 25%, respectively.
  • Achieved the 3rd consecutive quarter of net income and 11th consecutive quarter of improvement in adjusted EBITDA(1) as a percentage of revenue.
  • Reduced borrowings outstanding under the Asset Based Loan by 58% (or $4.4 million) compared to year-end 2023.

Full Year 2024 Profitability Outlook

As a result of the numerous cost reductions and efficiency gains implemented throughout 2023, the Company expects a substantial increase in margins compared to 2023. In 2023, our gross margin was 13% and our net income was $24.7 million. Flotek expects 2024 adjusted gross profit margin(2) to range between 18% and 22%, as compared to 2023 adjusted gross profit margin(1) of 15%. The Company expects 2024 adjusted EBITDA(2) to range between $10 million and $16 million as compared to $1.5 million in 2023(1)

Management Commentary

Chief Executive Officer Dr. Ryan Ezell commented, "Our first quarter results continue the positive financial and operational trends that began during 2022.  We achieved our third consecutive quarter of net income. Adjusted EBITDA(1) during the quarter exceeded the entire year of 2023. Using the mid-point of our guidance, we expect a nearly 800% increase in annual adjusted EBITDA(2) versus 2023(1).

During the quarter we realized 19% sequential growth in our ProFrac related revenue while our data analytics segment revenues increased 18% from the fourth quarter of 2023. While our first quarter external chemistry customer sales realized 27% year over year growth, they declined sequentially, which is consistent with the first quarter in each of the last three years. We expect these revenues will show a substantial increase during the second quarter and we anticipate annual growth in external chemistry customer sales for 2024.

Our numerous financial improvements continue to validate the initiatives executed over the past 18 months aimed at building a resilient business that can sustain profitability through the volatility inherent in our industry."

First Quarter 2024 Financial Results

  • Revenue: Flotek reported total revenues of $40.4 million for the first quarter 2024, which was a decrease of $7.6 million, or 16%, compared to total revenues of $48.0 million for the first quarter 2023. The decline in revenue compared to the first quarter 2023 was the result of lower related party activity that was partially offset by a 13% increase in revenue from external customers.

    Revenue from external chemistry customers during the first quarter 2024 declined by approximately $6.0 million as compared to the fourth quarter 2023 due primarily to normal seasonal declines. The Company anticipates external chemistry customer revenues to increase significantly in the second quarter 2024.

    Revenue associated with the Company's data analytics segment increased to $1.7 million, an 18% improvement as compared to the fourth quarter 2023. Revenues from data analytics totaled $2.5 million during the first quarter 2023.

  • Gross Profit: The Company generated gross profit of $8.8 million during the first quarter 2024 as compared to gross profit of $1.9 million for the first quarter 2023. The improvement in first quarter 2024 gross profit was the result of successful initiatives to drive cost improvements with respect to freight, logistics and materials, and revenue attributable to the estimated annual minimum chemistry purchase requirements contained in the ProFrac supply agreement. The measurement period during 2023 for annual minimum chemistry purchase requirements was June 1, 2023 through December 31, 2023.

  • Adjusted Gross Profit (Non-GAAP)(1): Flotek generated adjusted gross profit of $10.1 million during the first quarter 2024 compared to adjusted gross profit of $2.6 million for the first quarter 2023. Adjusted gross profit excludes non-cash items, primarily amortization of contract assets.

  • Selling, General and Administrative ("SG&A") Expense: SG&A expense totaled $6.1 million for the first quarter 2024 compared to $6.5 million for the first quarter 2023. The improvement was the result of lower personnel costs and professional fees during the 2024 period.

  • Net Income and EPS: Flotek reported net income of $1.6 million, or $0.05 per diluted share, for the first quarter 2024. This compares to net income of $21.3 million, or $(0.12) per diluted share, for the first quarter 2023. Net income for the first quarter 2023 benefited from a $26.1 million non-cash gain related to the fair value adjustment of the Company's convertible notes, as well as a $4.5 million gain from the partial forgiveness of the Company's PPP loan.

  • Adjusted EBITDA (Non-GAAP)(1): Adjusted EBITDA was $4.0 million in the first quarter 2024 as compared to negative $3.9 million in the first quarter 2023.

(1) A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information, including reconciliations to the most comparable GAAP measures.


(2) A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" section in this release for more information, including reconciliations to the most comparable GAAP measures. We are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, the future amortization of our contract assets, certain stock-based compensation costs and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure.

Conference Call Details

Flotek will host a conference call on May 8, 2024, at 9:00 a.m. CT (10:00 a.m. ET) to discuss its first quarter 2024 results. Participants may access the call through Flotek's website at www.flotekind.com under "News" within the Investor Relations section or by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785) approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

An updated corporate presentation that will be referenced on the call will be posted to the Investor Relations section of Flotek's website at www.flotekind.com prior to the start of the earnings conference call.

About Flotek Industries, Inc.

Flotek Industries, Inc. is an advanced technology-driven, green chemical and data analytics company providing unique and innovative completion solutions that have a proven, positive impact on sustainability and reducing the overall environmental impact of energy on air, land, water and people. Flotek has an intellectual property portfolio of over 170 patents and a global presence in more than 59 countries throughout North America, Latin America, the Middle East and North Africa. Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions which improve well performance and allow its customers to generate higher returns on invested capital.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK". For additional information, please visit www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.

FLOTEK INDUSTRIES, INC.
 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)

 


March 31, 2024


December 31, 2023

ASSETS




Current assets:




Cash and cash equivalents

$           5,219


$                 5,851

Restricted cash

100


102

Accounts receivable, net of allowance for credit losses of $374 and $745 at March 31, 2024 and December 31, 2023, respectively

10,718


13,687

Accounts receivable, related party, net of allowance for credit losses of $0 at each March 31, 2024 and December 31, 2023

38,655


34,569

Inventories, net

13,871


12,838

Other current assets

2,686


3,564

Current contract asset

7,019


5,836

Total current assets

78,268


76,447

Long-term contract assets

66,369


68,820

Property and equipment, net

5,061


5,129

Operating lease right-of-use assets

4,336


5,030

Deferred tax assets, net

91


300

Other long-term assets

1,725


1,787

TOTAL ASSETS

$       155,850


$             157,513





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




Accounts payable

$         35,952


$               31,705

Accrued liabilities

3,365


5,890

Income taxes payable

78


45

Current portion of operating lease liabilities

2,083


2,449

Current portion of finance lease liabilities

13


22

Asset-based loan

3,111


7,492

Current portion of long-term debt

179


179

Total current liabilities

44,781


47,782

Deferred revenue, long-term

35


35

Long-term operating lease liabilities

7,121


7,676

Long-term debt

15


60

TOTAL LIABILITIES

51,952


55,553

Commitments and contingencies




Stockholders' equity:




Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding


Common stock, $0.0001 par value, 240,000,000 shares authorized; 30,772,837 shares issued and 29,661,130 shares outstanding at March 31, 2024; 30,772,837 shares issued and 29,664,130 shares outstanding at December 31, 2023

3


3

Additional paid-in capital

463,484


463,140

Accumulated other comprehensive income

169


127

Accumulated deficit

(325,244)


(326,806)

Treasury stock, at cost; 1,111,707 and 1,108,707 shares at March 31, 2024 and December 31, 2023, respectively

(34,514)


(34,504)

Total stockholders' equity

103,898


101,960

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$       155,850


$               57,513

 

FLOTEK INDUSTRIES, INC.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except per share data)

 



Three Months Ended March 31,



2024


2023

Revenue:





Revenue from external customers


$               13,180


$               11,652

Revenue from related party


27,194


36,355

Total revenues


40,374


48,007

Cost of goods sold


31,553


46,127

Gross profit


8,821


1,880

Operating costs and expenses:





Selling, general, and administrative


6,084


6,451

Depreciation


220


176

Research and development


406


614

Severance costs


3


2,223

Gain in fair value of Contract Consideration Convertible Notes Payable



(26,095)

Total operating costs and expenses


6,713


(16,631)

Income from operations


2,108


18,511

Other income (expense):





Paycheck protection plan loan forgiveness



4,522

Interest expense


(278)


(1,672)

Other expense, net


(26)


(9)

Total other income (expense), net


(304)


2,841

Income before income taxes


1,804


21,352

Income tax expense


(242)


(9)

Net income


$                 1,562


$               21,343






Income (loss) per common share:





Basic


$                   0.05


$                   1.30

Diluted


$                   0.05


$                 (0.12)






Weighted average common shares:





Weighted average common shares used in computing basic income (loss) per common share


29,431


16,468

Weighted average common shares used in computing diluted income (loss) per common share


30,316


26,462

 

 

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 


Three Months Ended March 31,


2024


2023

Cash flows from operating activities:




Net income

$                1,562


$              21,343

Adjustments to reconcile net income to net cash provided by operating activities:




Change in fair value of contingent consideration

(26)


(359)

Change in fair value of Contract Consideration Convertible Notes Payable


(26,095)

Amortization of convertible note issuance costs


83

Payment-in-kind interest expense


1,571

Amortization of contract assets

1,267


1,251

Depreciation and amortization

220


176

Amortization of asset-based loan origination costs

85


Provision for credit losses, net of recoveries

32


23

Provision for excess and obsolete inventory

285


258

Non-cash lease expense

694


977

Stock compensation expense

311


(1,112)

Deferred income tax expense (benefit)

209


(6)

Paycheck protection plan loan forgiveness


(4,522)

Changes in current assets and liabilities:




Accounts receivable

2,937


3,504

Accounts receivable, related party

(4,086)


(3,546)

Inventories

(1,318)


(441)

Other assets

856


(470)

Accounts payable

4,246


8,554

Accrued liabilities

(2,499)


1,236

Operating lease liabilities

(921)


(1,190)

Income taxes payable

33


(87)

Interest payable


(8)

Net cash provided by operating activities

3,887


1,140

 

 

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(continued)

 


Three Months Ended March 31,


2024


2023

Cash flows from investing activities:




Capital expenditures

(152)


(157)

Net cash used in investing activities

(152)


(157)

Cash flows from financing activities:




Payment for forfeited stock options


(617)

Payments on long term debt

(45)


(15)

Proceeds from asset-based loan

38,800


Payments on asset-based loan

(43,181)


Payments to tax authorities for shares withheld from employees

(9)


(200)

Proceeds from issuance of stock

33


20

Payments for finance leases

(9)


(6)

Net cash used in financing activities

(4,411)


(818)

Effect of changes in exchange rates on cash and cash equivalents

42


(21)

Net change in cash and cash equivalents and restricted cash

(634)


144

Cash and cash equivalents at the beginning of period

5,851


12,290

Restricted cash at the beginning of period

102


100

Cash and cash equivalents and restricted cash at beginning of period

5,953


12,390

Cash and cash equivalents at end of period

5,219


12,433

Restricted cash at the end of period

100


101

Cash and cash equivalents and restricted cash at end of period

$                  5,319


$                12,534

 

 

FLOTEK INDUSTRIES, INC.
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands)

 




Three Months Ended March 31,


Twelve Months
Ended December 31,



2024


2023


2023








Gross profit


$            8,821


$            1,880


$                     24,263

Stock compensation expense


4


(140)


(132)

Severance and retirement


9


15


29

Contingent liability revaluation


(26)


(359)


(527)

Amortization of contract assets


1,267


1,251


5,033

Adjusted Gross profit (Non-GAAP) (1)


$          10,075


$            2,647


$                     28,666








Net income


$            1,562


$          21,343


$                     24,713

Interest expense


278


1,672


2,857

Income tax expense


242


9


149

Depreciation and amortization


220


176


734

EBITDA (Non-GAAP) (1)


$            2,302


$          23,200


$                     28,453

Stock compensation expense


311


(1,112)


(268)

Severance and retirement


12


2,238


(17)

Contingent liability revaluation


(26)


(359)


(527)

Gain on disposal of assets




(38)

PPP loan forgiveness



(4,522)


(4,522)

Contract Consideration Convertible Notes Payable revaluation adjustment



(26,095)


(29,969)

Amortization of contract assets


1,267


1,251


5,033

Non-Recurring professional fees


160


1,548


3,343

Adjusted EBITDA (Non-GAAP) (1)


$            4,026


$           (3,851)


$                 1,488









(1) Management believes that adjusted gross profit, EBITDA and adjusted EBITDA for the three months ended March 31, 2024,

     2023, and 12 months ended December 31, 2023, are useful to investors to assess and understand operating performance,

     especially when comparing those results with previous and subsequent periods. Management views the income and

     expenses noted above to be outside of the Company's normal operating results.  Management analyzes operating results

     without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash

     flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-announces-first-quarter-2024-results-reflecting-improved-profitability-302138751.html

SOURCE Flotek Industries, Inc.

FAQ

What were Flotek's total revenues in Q1 2024?

Flotek reported total revenues of $40.4 million in Q1 2024.

How did Flotek's net income change from Q1 2023 to Q1 2024?

Net income decreased from $21.3 million in Q1 2023 to $1.6 million in Q1 2024.

What is Flotek's stock symbol?

Flotek's stock symbol is FTK.

What is Flotek's CEO's name?

Flotek's CEO is Dr. Ryan Ezell.

What financial improvements were highlighted in Flotek's Q1 2024 results?

Flotek highlighted improvements in gross profit, adjusted gross profit, and adjusted EBITDA in Q1 2024.

Flotek Industries, Inc.

NYSE:FTK

FTK Rankings

FTK Latest News

FTK Stock Data

230.62M
18.05M
39.44%
14.07%
2.02%
Oil & Gas Equipment & Services
Miscellaneous Chemical Products
Link
United States of America
HOUSTON